| Typicality: | 0.407 |
| Saliency: | 0.420 |
| ultimately | 4 | degree |
| for diseases | 4 | transitive-object |
| to the public | 4 | transitive-object |
| researcher → develop → new therapies | 26 |
| researcher → create → novel therapies | 7 |
| researcher → design → new therapies | 4 |
| researcher → develop → other therapies | 4 |
| researcher → develop → novel therapies | 3 |
| researcher → develop → innovative therapies | 3 |
| researcher → bring → new therapies | 3 |
| negative | neutral | positive |
| 0.023 | 0.466 | 0.512 |
| Raw frequency | 50 |
| Normalized frequency | 0.420 |
| Modifier score | 0.700 |
| Perplexity | 481.994 |